SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-272903
Filing Date
2020-10-20
Accepted
2020-10-20 16:37:59
Documents
5
Effectiveness Date
2020-10-20

Document Format Files

Seq Description Document Type Size
1 S-8 d49522ds8.htm S-8 85181
2 EX-5.1 d49522dex51.htm EX-5.1 11497
3 EX-23.2 d49522dex232.htm EX-23.2 2063
4 GRAPHIC g49522ex5-1dsp1.jpg GRAPHIC 4249
5 GRAPHIC g49522ex5-1dsp2.jpg GRAPHIC 3174
  Complete submission text file 0001193125-20-272903.txt   110298
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-249568 | Film No.: 201248663
SIC: 2836 Biological Products, (No Diagnostic Substances)